Login

|

Register

  • Home
    • Amazon FBA Support

      Amazon handed prep work back to sellers, and the consequences of getting it wrong land on you rather than on them. A carton that arrives wrong gets refused, refused stock sits somewhere earning nothing, and a launch date moves.

      Amazon FBM Support

      FBM keeps the things worth keeping. Your packaging, customer data & margin. It also puts Amazon’s performance metrics directly on your dispatch times, which is a comfortable trade at home and a much harder one from four thousand miles away.

      Direct-to-Consumer Fulfilment

      On a marketplace, a slow delivery is the marketplace’s fault. On your own store it is yours. The box that arrives, the day it arrives and how easy it is to send back are all part of what someone bought, and they decide whether a first order becomes a second one.

      Returns, Reworks & Recycling

      Treated as a cost, a return is written off twice, once on the refund and again on the unit. Treated as inventory, a lot of it goes back on sale. What decides which of those happens is how quickly the unit gets looked at and how far it had to travel to be looked at.

      Warehouse Location

      Stock held inside the market it sells into arrives as a domestic delivery. No customs event on the order, and nothing for your customer to settle before the courier hands the parcel over. Ours sits in the UK, the Netherlands and the US, which covers...

  • Software
  • Integrations
  • Contact

Health and Wellness

Health and Wellness in Europe: What Cross-Border Brands Need to Know

Europe is a sophisticated wellness market. Customers value quality, ingredient transparency and credible sourcing, and they’re willing to pay for it. US, Canadian and UK brands with those characteristics often outperform their domestic competitors. The hard part isn’t building the market position. It’s navigating the regulatory framework that protects it.

Expandly takes health and wellness brands into Europe with the compliance, listings and logistics built around how supplement, nutrition and wellness products actually move through European markets.

In this section

01

The market filters for quality.

03

Ashwagandha is under regulatory pressure

05

CBD remains restricted

02

Ingredient compliance is a continuous workstream

04

EFSA upper limits are tightening

The landscape right now

Recurring themes across our coverage: ingredient watch, novel food, EFSA dosage limits, CBD, sports nutrition supply, supplement regulations.

Novel food catalogue update

Latest EU novel food catalogue update authorises 34 probiotic strains for EU market entry, opening previously restricted product categories for supplement and wellness brands.

34 strains

EU Novel Food Catalogue

Ashwagandha under regulatory review

Ashwagandha dossiers are being reassessed at EU and member-state level following India’s ban on the leaf. Brands with ashwagandha SKUs should track positions closely.

Under review

EU and member-state food authorities

EFSA upper limits tightening

EFSA is lowering upper limits across multiple common supplement ingredients, with formulation implications for brands at the upper end of US-typical doses.

Multiple ingredients

EFSA scientific opinions

UK CBD approvals frozen

The UK Food Standards Agency has frozen new CBD approvals until late 2026 pending further safety review. The door is closed for new market entrants and reformulations.

Frozen

– **Source:** UK FSA

EU sports nutrition supply expanding

FrieslandCampina has committed €90 million to expand EU whey protein capacity, anchoring local supply for sports and wellness brands serving the European market.

€90M

FrieslandCampina investment announcement

Global Expansion Pathway

How Expandly works with health and wellness brands

The brands we typically work with in this segment look like this: established US or Canadian supplement or wellness companies in the $5M–$50M revenue range, with strong DTC and Amazon presence at home, and Europe as the next obvious growth market. The regulatory and ingredient complexity is the main thing keeping them from moving.

Our approach is to start with an ingredient and claims audit against the EU and UK rules. Where products are clear, we move to launch. Where products need reformulation, claim changes or novel food authorization tracking, we sequence the work so launch isn’t delayed any longer than it needs to be.

For supplement brands specifically, we also handle category-specific compliance: novel food positions, claims review against EFSA register, country-specific food supplement notifications, and Responsible Person setup where required.

This sits across step two (Compliance) and step four (Omni-Channel) of the Global Expansion Pathway, with ingredient and claims work front-loaded so launch timing is predictable.

What's changing in the next 12 months

Ingredient regulation in health and wellness moves continuously and staying compliant requires continuous attention. Here are some of the significant items on the horizon.

Novel food catalogue updates

New ingredient authorisations and reassessments continue to flow through the EU novel food catalogue, opening (and occasionally closing) doors for specific ingredients on a rolling basis.

Ongoing

EU Novel Food Catalogue

Ashwagandha safety decisions

EU and member-state safety reassessments of ashwagandha are progressing through 2026. Final positions are expected to clarify which product formats and dose levels remain sellable.

2026

EU and member-state food authorities

EFSA upper limit reviews

Further EFSA upper limit reviews are scheduled for additional supplement ingredients through 2026, with formulation implications expected to compound across the year.

Through 2026

EFSA workplan

CBD position reviews

UK CBD approvals remain on hold; further EU CBD safety reviews are pending. Position likely to clarify through late 2026 with implications for new SKU launches.

Late 2026

UK FSA; EU safety reviews

EU AI Act full enforcement

From August 2026, the EU AI Act applies to AI-powered claims, chatbots and recommendation systems used in supplement and wellness ecommerce. Transparency and conformity obligations attach.

1 Aug 2026

EU AI Act

Health And Wellness Blog

Latest insights on health and wellness

Europe

Europe rewards health and wellness brands that take ingredient quality seriously. The regulatory framework is one of the ways the market filters for them.

European customers in this category increasingly buy with the label, the ingredient list and the source country in mind. The US and Canadian brands that win here are the ones whose product quality genuinely meets that scrutiny — and whose compliance work matches the standard of their product.

Three things separate the brands who scale cleanly from those who don’t:

  1. They sort the ingredient compliance position before they sort the channel mix.
  2. They build claims that hold up to EFSA scrutiny, not just marketing instinct.
  3. They track novel food updates as a continuous workstream, not a one-time launch task.

The European wellness opportunity isn’t going anywhere. It’s getting bigger and more sophisticated each year. The brands that show up properly are the ones that scale.

Country guides

How this varies by country

🇬🇧

United Kingdom

🇩🇪

Germany

🇫🇷

France

🇳🇱

Nertherlands

🇪🇸

Spain

🇮🇹

Italy

upcoming events

Related events

Coming Sooon

EU health supplement market entry: the 2026 compliance guide for US brands
Health Wellness
Cherity

EU Health Supplement Market Entry for US Brands : The 2026 Compliance Guide

The European health supplement market exceeds EUR 10 billion in 2026, but EU rules differ sharply from the US. Before placing a product on the EU market, US brands must clear Novel Food status, map health claims to the EU permitted list, check member state ingredient restrictions, and meet FIC labeling and PPWR packaging requirements.

Read More »
EU sports nutrition market entry compliance for US brands
Health Wellness
Cherity

EU Sports Nutrition Market Entry: What US Brands Need to Comply With Before Shipping the First Unit

The EU sports nutrition market is worth $6.61 billion in 2026. Before a single unit ships, US brands must answer five compliance questions in order: Novel Food status, EU permitted health claims, member state ingredient restrictions, FIC-compliant labeling and PPWR packaging. The sequence matters, and each question has a definite answer rather than guesswork.

Read More »

frequently asked questions

Common questions

What's the difference between a food supplement and a novel food in the EU?

A food supplement is a regulated category of concentrated nutrients sold in dosed form. A novel food is any food (or supplement ingredient) not consumed to a significant degree in the EU before May 1997. Novel foods need explicit authorization before sale; many supplement ingredients fall in this category.

Tighter than in the US. The EU Register of Nutrition and Health Claims sets out which claims can be made for which substances. Off-register claims attract enforcement quickly. Claims work has to be done before listings go live.

Some yes, some no. Dose levels, ingredient combinations and even ingredient sources can affect whether a US formulation is sellable in the EU. We audit before recommending launch versus reformulation.

CBD remains restricted in many EU countries and in flux in the UK. Most EU CBD safety reviews are not yet complete, and approved CBD product types are limited. Brands selling CBD products in the US should expect a slower European route to market.

Cosmetics require an RP. Food supplements have different but parallel requirements depending on country — typically a Food Business Operator established in the EU. We set this up as part of the launch sequence.

If this sounds like your world,
let's talk.

Expandly helps US ecommerce brands expand into Europe

Service tiers

Self-Serve

Guided

VIP

Ready to talk?

If you’re a US, Canadian or UK health, wellness or supplement brand planning European expansion, book a call.